ArticleColombia medica (Cali, Colombia)
Trends in cancer incidence and mortality in Manizales, Colombia, 2008-2017.
Article in Colombia medica (Cali, Colombia). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 5 citations in OpenAlex.
- Potential Benefits of Complementary Therapies for Women with Breast Cancer Undergoing Oncological Treatment: A Systematic Review.Healthcare (Basel, Switzerland) · 2026Review
- Patterns of sex differences in cancer mortality in Colombia: a population-based analysis, 1980-2023.Lancet regional health. Americas · 2026Article
- A predictive nomogram of thyroid nodules based on deep learning ultrasound image analysis.Frontiers in endocrinology · 2025Article
- Survival of patients with mucosal melanoma in Cali, Colombia: a retrospective cohort study.BMC cancer · 2024Article
- Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto Region from 1987 to 2019.Frontiers in public health · 2023Observational
- Colorectal cancer survival in Manizales, Colombia, 2008-2017: a population-based study.Revista brasileira de epidemiologia = Brazilian journal of epidemiology · 2023Article
- Cancer incidence and mortality in the Metropolitan Area of Bucaramanga, Colombia, 2013-2017.Colombia medica (Cali, Colombia)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To describe cancer incidence and mortality trends in Manizales, Colombia, between 2008-2017. Methods: All incident cancer cases in Manizales collected by the Population-based Manizales Cancer Registry between January 1, 2008, and December 31, 2017, and all deaths caused by cancer in the same period, were included. The population at risk was obtained from the National Administrative Department of Statistics databases. Age-standardized incidence and mortality rates were calculated by sex and cancer site. Changes in trends were assessed using Joinpoint regression. Results: There were 11,188 incident cases, 56.7% in women. There were 4,996 cancer deaths, 52.6% in women. Breast, prostate, stomach, thyroid, lung, and colon cancers accounted for 50% of all incident cases. During this period, the incidence in women decreased and equaled that of men due to a significant decrease in cervical, stomach, and lung cancers, among others; likewise, mortality in women decreased slightly due to the reduction in deaths from cervical, stomach, esophagus, and connective tissue cancers. In contrast, in men, overall incidence and mortality remained unchanged. Conclusions: In Manizales, population aging has contributed to an increased burden of cancer. In terms of incidence and mortality, progress in the fight against this disease is still discrete. It is a priority to reinforce cancer control strategies with a differential approach by sex.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.